Jiangsu Hengrui Pharmaceuticals Co.,Ltd
600276.SS
Below: live stock price for Jiangsu Hengrui Pharmaceuticals Co.,Ltd (600276.SS), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
- Prev close
- $6.43
- Volume
- $9.56M
- Market cap
- $43.61B
- Currency
- USD (native CNY)
Financials
- 52w high
- ¥74.04
- 52w low
- ¥47.20
- 52w change
- -12.40%
- Day high
- ¥48.72
- Day low
- ¥47.37
- P/E (TTM)
- 39.05
- Forward P/E
- 27.6
- PEG
- 0.93
- Price / Book
- 5.03
- Beta (5Y)
- 0.17
- Enterprise value
- 272.96B
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- EPS (TTM)
- ¥1.22
- Forward EPS
- ¥1.73
- Dividend yield
- 0.43%
- Dividend rate
- ¥0.20
- Payout ratio
- 16.39%
- Revenue (TTM)
- 32.56B
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Debt / Equity
- 0.11
- Current ratio
- 9.23
- Quick ratio
- 8.36
- Profit margin
- 24.93%
- Gross margin
- 86.27%
- Return on assets
- 8.80%
- Return on equity
- 14.54%
- Shares outstanding
- 6.38B
- Float
- 3.77B
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Analyst & Risk
- Beta (vs S&P 500)
- 0.17
- very stable
- 52-week change
- -12.40%
- Debt / Equity
- 0.11
- low leverage
- Current ratio
- 9.23
- Quick ratio
- 8.36
- ROE
- 14.54%
- ROA
- 8.80%
- PEG ratio
- 0.93
- potentially undervalued
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- Revenue growth
- 13.00%
- Earnings growth
- 13.30%
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Insider holdings
- 46.26%
- Institutional
- 16.59%
Recent news
- Uber reveals an unexpected problem behind the AI boomTheStreet3m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.5m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.7m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory8m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool9m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire10m ago
- Kupcho seizes slim lead in US Women's Open at RivieraAFP11m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily3m ago
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.